Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | USP2 | O75604 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 2/20 | 1.00 |
| ▸ | CRYAB | P02511 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | PTGES | O14684 | 4/20 | 0.79 |
| ▸ | FNTA | P49354 | 1/20 | 0.74 |
| ▸ | FNTB | P49356 | 1/20 | 0.74 |
| ▸ | CRYAA | P02489 | 1/20 | 0.71 |
| ▸ | ACHE | P22303 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.61 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.61 |
| ▸ | HMGCR | P04035 | 1/20 | 0.61 |
| ▸ | PREP | P48147 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lanosterol SCHEMBL18688634 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| Lanosterol SCHEMBL1242765 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| Lanosterol SCHEMBL17428540 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| Lanosterol SCHEMBL288881 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| Lanosterol SCHEMBL11914239 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| Lanosterol SCHEMBL1952146 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| Lanosterol SCHEMBL20225105 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| Lanosterol SCHEMBL15977092 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| Lanosterol SCHEMBL21348006 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| Lanosterol SCHEMBL244737 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 708 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3989943-B1 | COMPOSITION COMPRISING AT LEAST ONE TRITERPENE AND/OR AT LEAST ONE TRITERPENOID AND/OR AT LEAST ONE OF THE GLYCOSYLATED FORMS THEREOF | TILMAN (BE) | 2026-05-20 | — | — | EP | claimed |
| US-20260014065-A1 | PHYTOCHEMICAL INFUSED COSMETIC COMPOSITIONS AND THERAPEUTIC USES THEREOF | Dewey Beauty LLC (US) | 2026-01-15 | — | — | US | claimed |
| CN-119569680-A | Carbonic anhydrase binding ligand and preparation method and application thereof | 武汉工程大学 | 2025-03-07 | — | — | CN | claimed |
| CN-119183354-A | Composition, use thereof and material comprising same | 李平 | 2024-12-24 | — | — | CN | claimed |
| US-20240350455-A1 | COMPOSITIONS AND METHODS COMPRISING A COMBINATION OF SEROTONERGIC DRUGS | CAAMTECH, INC. (US) | 2024-10-24 | — | — | US | claimed |
| WO-2024124354-A1 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING PAIN OR OTHER DISORDERS | AIMA INC. (CA) | 2024-06-20 | — | — | WO | claimed |
| US-20230338329-A1 | CANNABINOID EMULSION COMPOSITION AND METHOD OF MANUFACTURING | GORE DOUGLAS (US) | 2023-10-26 | — | — | US | claimed |
| WO-2023108277-A1 | CANNABINOID AND PSYCHEDELIC FORMULATIONS COMPRISING HYDROTROPIC AGENTS | AGILE PHARMACEUTICALS SOLUTIONS INC. (CA) | 2023-06-22 | — | — | WO | claimed |
| US-20230036051-A1 | CANNABINOID STORAGE STABILITY | Resurgent Biosciences, Inc. (US) | 2023-02-02 | — | — | US | claimed |
| US-20220362158-A1 | COMPOSITION COMPRISING AT LEAST ONE TRITERPENE AND/OR AT LEAST ONE TRITERPENOID AND/OR AT LEAST ONE OF THE GLYCOSYLATED FORMS THEREOF | ELEONOR (BE) | 2022-11-17 | — | — | US | claimed |
| EP-0476054-A1 | METHOD FOR TREATING VIRAL INFECTION | HERMAN, Stephen (US) | 1992-03-25 | — | — | EP | claimed |
| US-5086076-A | For treating aids | WESTERN HOLDING COMPANY LIMITED (LI) | 1992-02-04 | — | — | US | claimed |
| EP-0427781-A4 | OZONIDES OF TERPENES AND THEIR MEDICAL USES | — | 1991-08-21 | — | — | EP | claimed |
| EP-0427781-A1 | OZONIDES OF TERPENES AND THEIR MEDICAL USES | HERMAN, Stephen (US) | 1991-05-22 | — | — | EP | claimed |
| US-4983637-A | PARENTERAL ADMINISTRATION OF OZONIDES OF TERPENES | CLIVEDEN LTD. (BS) | 1991-01-08 | — | — | US | claimed |
| WO-1990014764-A1 | METHOD FOR TREATING VIRAL INFECTION | HERMAN STEPHEN (US) | 1990-12-13 | — | — | WO | claimed |
| WO-1989012626-A1 | OZONIDES OF TERPENES AND THEIR MEDICAL USES | HERMAN STEPHEN (US) | 1989-12-28 | — | — | WO | claimed |
| US-4748161-A | Triterpenyl esters of organic acids and hypolipidemic agents composed of them | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1988-05-31 | — | — | US | claimed |
| CN-85109752-A | Preparation triterpenoid organic acid ester and the method that contains the hypolipidemic agents of this compounds | — | 1986-12-17 | — | — | CN | claimed |
| EP-0166542-A2 | Triterpenyl esters of organic acids, process for their production, and hypolipidemic agents composed of them | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1986-01-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240350455-A1 | COMPOSITIONS AND METHODS COMPRISING A COMBINATION OF SEROTONERGIC DRUGS | HTR1A, HTR2A, HTR1B | MAPT 1761/4885USP2 3145/4885ALDH1A1 2647/4885 |
| US-20260014065-A1 | PHYTOCHEMICAL INFUSED COSMETIC COMPOSITIONS AND THERAPEUTIC USES THEREOF | DHCR24, CNR2, DSG1 | MAPT 2834/4885USP2 3673/4885ALDH1A1 1504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.